Hematopoietic and Lymphatic System Neoplasm Clinical Trials

53 recruiting

Hematopoietic and Lymphatic System Neoplasm Trials at a Glance

53 actively recruiting trials for hematopoietic and lymphatic system neoplasm are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 24 trials, with the heaviest enrollment activity in Rochester, Seattle, and Jacksonville. Lead sponsors running hematopoietic and lymphatic system neoplasm studies include Mayo Clinic, City of Hope Medical Center, and Fred Hutchinson Cancer Center.

Browse hematopoietic and lymphatic system neoplasm trials by phase

Treatments under study

About Hematopoietic and Lymphatic System Neoplasm Clinical Trials

Looking for clinical trials for Hematopoietic and Lymphatic System Neoplasm? There are currently 53 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hematopoietic and Lymphatic System Neoplasm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hematopoietic and Lymphatic System Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 53 trials

Recruiting
Not Applicable

Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person

Hematopoietic and Lymphatic System NeoplasmAdvanced Malignant Solid Neoplasm
Fred Hutchinson Cancer Center80 enrolled2 locationsNCT07141407
Recruiting
Not Applicable

Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease

Acute Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmChronic Graft Versus Host Disease
Fred Hutchinson Cancer Center45 enrolled1 locationNCT07535008
Recruiting
Not Applicable

Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial

Hematopoietic and Lymphatic System Neoplasm
Fred Hutchinson Cancer Center40 enrolled1 locationNCT07052630
Recruiting
Phase 1

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Hematopoietic and Lymphatic System Neoplasm
City of Hope Medical Center42 enrolled1 locationNCT07025538
Recruiting
Not Applicable

Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocial Response in Participants

Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmPsychiatric Disorder
Ohio State University Comprehensive Cancer Center32 enrolled1 locationNCT07216534
Recruiting
Phase 2

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Hematopoietic and Lymphatic System NeoplasmMetastatic Malignant Solid NeoplasmDepression+1 more
University of Washington18 enrolled1 locationNCT07336238
Recruiting
Phase 1Phase 2

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Hematopoietic and Lymphatic System NeoplasmMetastatic Malignant Solid NeoplasmStage IV Colorectal Cancer AJCC v8+4 more
National Cancer Institute (NCI)58 enrolled23 locationsNCT05691491
Recruiting
Not Applicable

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Wake Forest University Health Sciences50 enrolled1 locationNCT06709404
Recruiting
Not Applicable

A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors

Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
Mayo Clinic660 enrolled3 locationsNCT06198010
Recruiting
Not Applicable

Distance-Based Exercise to Preserve Function and Prevent Disability

Hematopoietic and Lymphatic System NeoplasmLocalized Malignant Solid Neoplasm
Alliance for Clinical Trials in Oncology104 enrolled17 locationsNCT07059884
Recruiting
Not Applicable

Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Roswell Park Cancer Institute28 enrolled1 locationNCT06798701
Recruiting
Not Applicable

CREATE: Art for Children With Cancer

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
OHSU Knight Cancer Institute72 enrolled1 locationNCT06342453
Recruiting
Phase 1

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Hematopoietic and Lymphatic System NeoplasmAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more
City of Hope Medical Center46 enrolled3 locationsNCT07020533
Recruiting
Not Applicable

Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Mayo Clinic30 enrolled2 locationsNCT07089927
Recruiting

Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
University of Southern California10 enrolled1 locationNCT07306338
Recruiting

Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Mayo Clinic134 enrolled1 locationNCT07477886
Recruiting
Not Applicable

Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Roswell Park Cancer Institute150 enrolled1 locationNCT06565260
Recruiting
Not Applicable

Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies

Hematopoietic and Lymphatic System Neoplasm
Fred Hutchinson Cancer Center30 enrolled1 locationNCT04829136
Recruiting

Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
University of Southern California50 enrolled1 locationNCT07456436
Recruiting

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+1 more
National Cancer Institute LAO5,000 enrolled140 locationsNCT02474160